Amend 004 - Hepatitis B Adult and Pediatric Vaccine - GlaxoSmithKline Inc.
Contract number E60PH-22HEPB/001/PH
Solicitation number E60PH-22HEPB/A
Contract award date
Expiry date
Amendment date
Amendment value CAD 8,257,621.63
Contract details
This contract was awarded to:
GlaxoSmithKline Inc.
Hepatitis B Adult and Pediatric Vaccine
- Business address
-
100 Milverton Dr Suite 800Mississauga, Ontario, L5R 4H1CA
- Notice type
- Request for Proposal
- Language(s)
-
English,French
- Selection criteria
- Lowest Price
Contract duration
The contract will be for a period of 36 month(s), from 2022/03/07 to 2025/03/31.
Total value of contract
This is the total value of this contract, which includes the initial contract value and the sum of all amendments.
CAD 21,595,100.80
Commodity - UNSPSC
- 51000000 - Drugs and Pharmaceutical Products
Trade agreements
-
Canadian Free Trade Agreement (CFTA)
-
Canada-Chile Free Trade Agreement (CCFTA)
-
Canada-Colombia Free Trade Agreement
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
World Trade Organization Agreement on Government Procurement (WTO GPA)
-
Canada-Honduras Free Trade Agreement
-
Canada-Korea Free Trade Agreement (CKFTA)
-
Canada-Panama Free Trade Agreement
-
Canada-Peru Free Trade Agreement (CPFTA)
-
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
-
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
Contact information
Contracting organization
- Organization
-
Department of Public Works and Government Services (PSPC)
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada
- Contracting authority
- Meunier, Sherry (SPAC/PSPC)
- Email
- sherry.meunier@tpsgc-pwgsc.gc.ca
Buying organization(s)
Related notices
Amendments made to this contract (4) A total of 4 amendments have been made to this contract. Click to collapse
This is a list of the amendments made to contract
E60PH-22HEPB/001/PH that is awarded to GlaxoSmithKline Inc..
Amendment number
|
Contract value
|
Award date
|
|---|---|---|
| 003 | CAD 21 595 100.80 | 2023/01/10 |
| 002 | CAD 21 595 100.80 | 2022/10/27 |
| 001 | CAD 21 595 100.80 | 2022/03/28 |
| 000 | CAD 21 595 100.80 | 2022/03/07 |
Tender notices (1) This contract has 1 related tender notices. Click to collapse
|
Title
|
Solicitation Number
|
Publication date
|
Closing date
|
|---|---|---|---|
| Hepatitis B Adult and Pediatrics | E60PH-22HEPB/A | 2022/01/06 | 2022/01/26 |
Contracts awarded (2) This contract has 2 related award notices. Click to collapse
This is a list of other contracts that were awarded related to solicitation number E60PH-22HEPB/A. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment date
|
Award date
|
More details |
|---|---|---|---|---|
| GlaxoSmithKline Inc. | E60PH-22HEPB/001/PH | 2024/03/07 | 2022/03/07 | Viewthe details of contract E60PH-22HEPB/001/PH for GlaxoSmithKline Inc. |
| Merck Canada Inc. | E60PH-22HEPB/002/PH | 2024/03/05 | 2022/03/07 | Viewthe details of contract E60PH-22HEPB/002/PH for Merck Canada Inc. |
Contract history (10) This contract has 10 related contracts. Click to collapse
This is a list of other contracts that were awarded and their amendments. Click the link under “More details” to view the contract details.
